96 related articles for article (PubMed ID: 38258323)
1. Referral of patients from rural primary care clinics to telemedicine vendors for opioid use disorder treatment: A mixed-methods study.
Lin C; Zhu Y; Mooney LJ; Ober A; Clingan SE; Baldwin LM; Calhoun S; Hser YI
J Telemed Telecare; 2024 Jan; ():1357633X231226261. PubMed ID: 38258323
[TBL] [Abstract][Full Text] [Related]
2. Stakeholder perspectives on a telemedicine referral and coordination model to expand medication treatment for opioid use disorder in rural primary care clinics.
Ober AJ; Dopp AR; Clingan SE; Curtis ME; Lin C; Calhoun S; Larkins S; Black M; Hanano M; Osterhage KP; Baldwin LM; Saxon AJ; Hichborn EG; Marsch LA; Mooney LJ; Hser YI
J Subst Use Addict Treat; 2024 Jan; 156():209194. PubMed ID: 37863356
[TBL] [Abstract][Full Text] [Related]
3. Care coordination between rural primary care and telemedicine to expand medication treatment for opioid use disorder: Results from a single-arm, multisite feasibility study.
Hser YI; Mooney LJ; Baldwin LM; Ober A; Marsch LA; Sherman S; Matthews A; Clingan S; Fei Z; Zhu Y; Dopp A; Curtis ME; Osterhage KP; Hichborn EG; Lin C; Black M; Calhoun S; Holtzer CC; Nesin N; Bouchard D; Ledgerwood M; Gehring MA; Liu Y; Ha NA; Murphy SM; Hanano M; Saxon AJ
J Rural Health; 2023 Sep; 39(4):780-788. PubMed ID: 37074350
[TBL] [Abstract][Full Text] [Related]
4. Is telemedicine the answer to rural expansion of medication treatment for opioid use disorder? Early experiences in the feasibility study phase of a National Drug Abuse Treatment Clinical Trials Network Trial.
Hser YI; Ober AJ; Dopp AR; Lin C; Osterhage KP; Clingan SE; Mooney LJ; Curtis ME; Marsch LA; McLeman B; Hichborn E; Lester LS; Baldwin LM; Liu Y; Jacobs P; Saxon AJ
Addict Sci Clin Pract; 2021 Apr; 16(1):24. PubMed ID: 33879260
[TBL] [Abstract][Full Text] [Related]
5. Strategies to recruit rural primary care providers to implement a medication for opioid use disorder (MOUD) focused integrated care model.
Cloutier RM; Cole ES; McDonough BL; Lomauro DA; Miller JP; Talbert AL; Bear TM; Bridges NC; Foulds AL; Taber R; Gordon AJ; Cochran GT; Kmiec J; Donohue JM; Kelley D; DiDomenico E; Adair D; Pringle JL
Implement Res Pract; 2023; 4():26334895231152808. PubMed ID: 37091535
[TBL] [Abstract][Full Text] [Related]
6. Mobile Telemedicine for Buprenorphine Treatment in Rural Populations With Opioid Use Disorder.
Weintraub E; Seneviratne C; Anane J; Coble K; Magidson J; Kattakuzhy S; Greenblatt A; Welsh C; Pappas A; Ross TL; Belcher AM
JAMA Netw Open; 2021 Aug; 4(8):e2118487. PubMed ID: 34448869
[TBL] [Abstract][Full Text] [Related]
7. Co-occurring substance use disorders among patients with opioid use disorder in rural primary care clinics.
Zhu Y; Baldwin LM; Mooney LJ; Saxon AJ; Kan E; Hser YI
J Subst Use Addict Treat; 2024 Mar; 158():209269. PubMed ID: 38097045
[TBL] [Abstract][Full Text] [Related]
8. Medication treatment for opioid use disorder among rural primary care patients.
Hser YI; Zhu Y; Baldwin LM; Mooney LJ; Saxon AJ
J Rural Health; 2024 Jan; 40(1):195-199. PubMed ID: 37495899
[TBL] [Abstract][Full Text] [Related]
9. Increasing buprenorphine access for veterans with opioid use disorder in rural clinics using telemedicine.
Brunet N; Moore DT; Lendvai Wischik D; Mattocks KM; Rosen MI
Subst Abus; 2022; 43(1):39-46. PubMed ID: 32078492
[No Abstract] [Full Text] [Related]
10. A scalable, automated warm handoff from the emergency department to community sites offering continued medication for opioid use disorder: Lessons learned from the EMBED trial stakeholders.
Ahmed OM; Mao JA; Holt SR; Hawk K; D'Onofrio G; Martel S; Melnick ER
J Subst Abuse Treat; 2019 Jul; 102():47-52. PubMed ID: 31202288
[TBL] [Abstract][Full Text] [Related]
11. Implications of Increased Access to Buprenorphine for Medical Providers in Rural Areas: A Review of the Literature and Future Directions.
Gregory HM; Hill VM; Parker RW
Cureus; 2021 Nov; 13(11):e19870. PubMed ID: 34976492
[TBL] [Abstract][Full Text] [Related]
12. Medications for opioid use disorder in rural primary care practices: Patient and provider experiences.
Bridges NC; Taber R; Foulds AL; Bear TM; Cloutier RM; McDonough BL; Gordon AJ; Cochran GT; Donohue JM; Adair D; DiDomenico E; Pringle JL; Gellad WF; Kelley D; Cole ES
J Subst Use Addict Treat; 2023 Nov; 154():209133. PubMed ID: 37543217
[TBL] [Abstract][Full Text] [Related]
13. Implementation of medication for opioid use disorder treatment in Indian health clinics in California: A qualitative evaluation.
Soto C; Miller K; Moerner L; Nguyen V; Ramos GG
J Subst Use Addict Treat; 2023 Dec; 155():209115. PubMed ID: 37399928
[TBL] [Abstract][Full Text] [Related]
14. Feasibility and acceptability of an online ECHO intervention to expand access to medications for treatment of opioid use disorder, psychosocial treatments and supports.
Salvador JG; Bhatt SR; Jacobsohn VC; Maley LA; Alkhafaji RS; Rishel Brakey H; Myers OB; Sussman AL
Subst Abus; 2021; 42(4):610-617. PubMed ID: 32814005
[No Abstract] [Full Text] [Related]
15. Barriers to Integrated Medication-Assisted Treatment for Rural Patients With Co-occurring Disorders: The Gap in Managing Addiction.
Snell-Rood C; Pollini RA; Willging C
Psychiatr Serv; 2021 Aug; 72(8):935-942. PubMed ID: 33530734
[TBL] [Abstract][Full Text] [Related]
16. Treating opioid use disorder in veterans with co-occurring substance use: a qualitative study with buprenorphine providers in primary care, mental health, and pain settings.
Frost MC; Soyer EM; Achtmeyer CE; Hawkins EJ; Glass JE; Hallgren KA; Williams EC
Addict Sci Clin Pract; 2023 May; 18(1):26. PubMed ID: 37143162
[TBL] [Abstract][Full Text] [Related]
17. From policy to practice: Pilot program increases access to medication for opioid use disorder in rural Colorado.
Sorrell TR; Weber M; Alvarez A; Beste N; Hollins U; Amura CR; Cook PF
J Subst Abuse Treat; 2020 Jul; 114():108027. PubMed ID: 32527514
[TBL] [Abstract][Full Text] [Related]
18. Syringe service program-based telemedicine linkage to opioid use disorder treatment: protocol for the STAMINA randomized control trial.
Watson DP; Swartz JA; Robison-Taylor L; Mackesy-Amiti ME; Erwin K; Gastala N; Jimenez AD; Staton MD; Messmer S
BMC Public Health; 2021 Mar; 21(1):630. PubMed ID: 33789642
[TBL] [Abstract][Full Text] [Related]
19. An examination of telehealth policy impacts on initial rural opioid use disorder treatment patterns during the COVID-19 pandemic.
Hughes PM; Verrastro G; Fusco CW; Wilson CG; Ostrach B
J Rural Health; 2021 Jun; 37(3):467-472. PubMed ID: 33720447
[TBL] [Abstract][Full Text] [Related]
20. Understanding opportunities and challenges with telemedicine-delivered buprenorphine during the COVID-19 pandemic.
Mattocks KM; Moore DT; Wischik DL; Lazar CM; Rosen MI
J Subst Abuse Treat; 2022 Aug; 139():108777. PubMed ID: 35346533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
